XORTX Therapeutics Inc.
XRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729214
No open-market purchases or sales by XORTX Therapeutics Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $92.8K in total; no superinvestor holds it.
Holders of 5% or more of XRTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of XORTX Therapeutics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Lincoln Alternative Strategies LLC | 13G | 9.90%572.5K shares | New | Oct 27, 20251 filing | Oct 27, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on XORTX Therapeutics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Oct 27, 20254:29 PM ET | Lincoln Alternative Strategies LLC | 13G | 9.90%572.5K shares | New | Oct 23, 2025 | SEC |
| May 15, 20253:14 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%178.0K shares | −5.00 ppfrom 9.99%Below 5% | Mar 31, 2025 | SEC |
| Feb 14, 20255:04 PM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%346.8K shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell XORTX Therapeutics Inc. shares.
No Form 144 notices for XORTX Therapeutics Inc. are on file.